{"id":"W2765414225","doi":"10.1182/blood-2017-09-804641","title":"Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Ibrutinib; Rituximab; Medicine; Follicular lymphoma; Oncology; Refractory (planetary science); Internal medicine; Idelalisib; Phases of clinical research; Clinical trial; Lymphoma; Leukemia; Chronic lymphocytic leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006876024,0.0002509413,0.0006012762,0.0001800425,0.0002136044,0.0001064818,0.0004099357,0.0002600055,0.0003478888],"category_scores_gemma":[0.003167091,0.0001964089,0.000191376,0.0001421851,0.0002844879,0.0001138211,0.0002041843,0.0002374198,0.0001846522],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003613941,"about_ca_system_score_gemma":0.007564513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005750862,"about_ca_topic_score_gemma":0.000127935,"domain_scores_codex":[0.9973622,0.0001178851,0.0005873975,0.0005552401,0.000710501,0.0006667862],"domain_scores_gemma":[0.9974312,0.0002352641,0.000257842,0.001627586,0.0001002384,0.0003479034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5387154,0.1319578,0.002296937,0.001279615,0.002029155,0.08444756,0.00260293,0.000003778814,0.109864,0.0003754591,0.01148109,0.1149463],"study_design_scores_gemma":[0.9397089,0.003279068,0.0005963329,0.0002718084,0.0002788206,0.0005796002,0.0000855897,0.0004006633,0.02646032,0.00002876002,0.02804558,0.0002645425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905085,0.0004828122,0.000005946406,0.0003914153,0.0004300159,0.001425109,0.00001288666,0.00007874607,0.006664599],"genre_scores_gemma":[0.9949816,0.00007152566,0.0003070872,0.0001612104,0.0006237699,0.0001231378,0.00002163211,0.00005438087,0.003655592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4009935,"threshold_uncertainty_score":0.9980617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06832704270368069,"score_gpt":0.3612379891516637,"score_spread":0.292910946447983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}